Liver Cancer Research
Investigators discover new gene that affects clearance of hepatitis C virusPosted: January 7, 2013
Scientists have discovered a new human interferon gene, Interferon Lambda 4 (IFNL4), that affects clearance of the hepatitis C virus. They also identified an inherited genetic variant within IFNL4 that predicts how people respond to treatment for hepatitis C infection.
Combining Angiogenesis-Targeted Treatments for Liver CancerPosted: May 29, 2012
In this trial, patients with unresectable hepatocellular carcinoma who are ineligible for a liver transplant or other local therapies will be given oral sorafenib at the standard approved dose and intravenous TRC105.